| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | bitter taste receptor activity | 1.71e-05 | 27 | 116 | 4 | GO:0033038 | |
| GeneOntologyMolecularFunction | taste receptor activity | 3.88e-05 | 33 | 116 | 4 | GO:0008527 | |
| GeneOntologyMolecularFunction | microtubule binding | 7.91e-05 | 308 | 116 | 9 | GO:0008017 | |
| GeneOntologyMolecularFunction | myosin phosphatase regulator activity | 1.99e-04 | 4 | 116 | 2 | GO:0017020 | |
| GeneOntologyMolecularFunction | centromeric DNA binding | 6.89e-04 | 7 | 116 | 2 | GO:0019237 | |
| GeneOntologyMolecularFunction | protein kinase activity | 7.47e-04 | 600 | 116 | 11 | GO:0004672 | |
| GeneOntologyMolecularFunction | tubulin binding | 8.87e-04 | 428 | 116 | 9 | GO:0015631 | |
| MousePheno | abnormal skin appearance | PDS5B PLK2 ABCA12 SPTA1 MAEA NFKBIZ TSC1 JAK2 DST TMCC2 WDFY3 RAPGEF2 MAPK7 TPH1 | 2.09e-06 | 473 | 91 | 14 | MP:0009931 |
| MousePheno | pallor | 3.38e-06 | 239 | 91 | 10 | MP:0003717 | |
| Domain | ARM-like | PDS5B SETX LRRK2 HEATR1 ARMCX2 ECPAS ARID1A TRRAP LTN1 WDFY3 STAG3 | 5.66e-07 | 270 | 110 | 11 | IPR011989 |
| Domain | - | 6.61e-06 | 222 | 110 | 9 | 1.25.10.10 | |
| Domain | Kinase-like_dom | NRBP1 PLK2 LRRK2 ARHGAP35 TRRAP MAP3K12 JAK2 NEK1 DST NEK5 MAPK7 PRKX CDK5 | 1.82e-05 | 542 | 110 | 13 | IPR011009 |
| Domain | ARM-type_fold | PDS5B LRRK2 HEATR1 ARMCX2 ECPAS ARID1A TRRAP LTN1 WDFY3 STAG3 | 3.20e-05 | 339 | 110 | 10 | IPR016024 |
| Domain | Pase-1_reg_su_16AB | 3.44e-05 | 2 | 110 | 2 | IPR017417 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | EDC3 SETX TBC1D30 CENPE CENPF MYO7A RPS9 LCA5L ZBTB41 ECPAS JAK2 FRY DST MTHFD1 ZNF408 MTCL1 | 3.82e-09 | 736 | 117 | 16 | 29676528 |
| Pubmed | NCOA2 EDC3 SETX NFKBIZ ZBTB41 HEATR1 ZBTB24 ZNF182 SEPSECS ALKBH8 GBP4 VPS33B MTHFD1 LTN1 CCSER2 AEBP2 PCNT | 1.40e-07 | 1084 | 117 | 17 | 11544199 | |
| Pubmed | NCOA2 CAD CENPE CENPF TSC1 JAKMIP3 OPA1 FRY DST SEC23IP MTCL1 WDFY3 RAPGEF2 GOLGA4 CDK5 PCNT | 1.56e-07 | 963 | 117 | 16 | 28671696 | |
| Pubmed | 2.49e-07 | 187 | 117 | 8 | 26460568 | ||
| Pubmed | PDS5B CENPC CENPF SPTA1 NMRAL1 TSC1 ZBTB41 HEATR1 CFAP210 ARID1A CCDC57 TRAP1 OR13D1 DST STXBP2 SEC23IP RPL3L MYBPC1 PCNT | 3.50e-07 | 1442 | 117 | 19 | 35575683 | |
| Pubmed | 1.01e-06 | 225 | 117 | 8 | 12168954 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | PDS5B CENPE CENPF MYO7A TSC1 ECPAS CCDC57 TRRAP OPA1 MTHFD1 ZNF408 | 1.01e-06 | 497 | 117 | 11 | 36774506 |
| Pubmed | NCOA2 NRBP1 PLK2 PPFIBP1 ZNF521 JAKMIP3 ARID1A FRY DST ZNF92 SEC23IP DENND6B PPP1R16B LRRCC1 WDFY3 RAPGEF2 PCNT | 1.47e-06 | 1285 | 117 | 17 | 35914814 | |
| Pubmed | EDC3 PPFIBP1 ECPAS ARID1A DST VPS33B CCSER2 NINL MTCL1 RAPGEF2 | 2.86e-06 | 446 | 117 | 10 | 24255178 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | PDS5B CAD CENPF RPS9 RTN3 RO60 HEATR1 ECPAS OPA1 TRAP1 VPS33B MTHFD1 SEC23IP TDRD6 CLUH GOLGA4 MYBPC1 | 5.83e-06 | 1425 | 117 | 17 | 30948266 |
| Pubmed | TBC1D30 PPFIBP1 ARHGAP35 ARMCX2 NEK1 TMCC2 LTN1 LRRCC1 UBR3 MBD5 | 6.89e-06 | 493 | 117 | 10 | 15368895 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | NCOA2 MAEA RTN3 ARHGAP35 ECPAS ARID1A CCDC57 TRRAP LRRC8D MAP3K12 JAK2 FAM13A RAPGEF2 MBD5 PRKX GOLGA4 PCNT | 1.03e-05 | 1489 | 117 | 17 | 28611215 |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 31838722 | ||
| Pubmed | Identification of a novel GOLGA4-JAK2 fusion gene in B-cell acute lymphoblastic leukaemia. | 1.12e-05 | 2 | 117 | 2 | 34697799 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 20506645 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 26930193 | ||
| Pubmed | Comparison of munc-18 and cdk5 expression in the nervous system during mouse embryogenesis. | 1.12e-05 | 2 | 117 | 2 | 10579588 | |
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 25189171 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 7851898 | ||
| Pubmed | 1.12e-05 | 2 | 117 | 2 | 30986824 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | PDS5B CAD SETX CENPC RPS9 TSC1 HEATR1 ARID1A TRRAP DST VPS33B MTHFD1 LTN1 TXNDC9 WDFY3 GOLGA4 | 1.26e-05 | 1353 | 117 | 16 | 29467282 |
| Pubmed | EDC3 SETX PPFIBP1 LRRK2 PKHD1L1 ARL6 DST MTHFD1 SEC23IP TXNDC9 RAPGEF2 GOLGA4 | 1.28e-05 | 777 | 117 | 12 | 35844135 | |
| Pubmed | PDS5B CAD CENPF HEATR1 ECPAS ARID1A TRRAP DST OASL CLUH PCNT | 1.35e-05 | 653 | 117 | 11 | 22586326 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MYO7A MAEA ARHGAP35 ARID1A TRRAP JAK2 DST ZNF408 TMCC2 NINL WDFY3 MBD5 PCNT PPP1R16A | 2.16e-05 | 1105 | 117 | 14 | 35748872 |
| Pubmed | 3.28e-05 | 472 | 117 | 9 | 38943005 | ||
| Pubmed | CDK5 functions as a tumor promoter in human colorectal cancer via modulating the ERK5-AP-1 axis. | 3.36e-05 | 3 | 117 | 2 | 27735944 | |
| Pubmed | LRRK2 Facilitates tau Phosphorylation through Strong Interaction with tau and cdk5. | 3.36e-05 | 3 | 117 | 2 | 26268594 | |
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 9763420 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 35596061 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 29748388 | ||
| Pubmed | 3.36e-05 | 3 | 117 | 2 | 20054236 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | EDC3 MYO7A PPFIBP1 MAEA HEATR1 OPA1 ARL6 NEK1 TRAP1 SEPSECS NEK5 SEC23IP NINL CLUH CDK5 | 3.83e-05 | 1321 | 117 | 15 | 27173435 |
| Pubmed | CAD EDC3 CENPE RPS9 HEATR1 ECPAS LRRC8D OPA1 TRAP1 MTHFD1 GLE1 OASL RPL3L PCNT | 3.96e-05 | 1168 | 117 | 14 | 19946888 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | CAD CENPE CENPF RTN3 TSC1 HEATR1 ARMCX2 OPA1 TRAP1 DST VPS33B SEC23IP TXNDC9 MCUB CLUH PCNT | 4.24e-05 | 1496 | 117 | 16 | 32877691 |
| Pubmed | 5.19e-05 | 284 | 117 | 7 | 29459677 | ||
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 5.54e-05 | 120 | 117 | 5 | 31413325 | |
| Pubmed | 6.70e-05 | 4 | 117 | 2 | 10852915 | ||
| Pubmed | 6.70e-05 | 4 | 117 | 2 | 15590698 | ||
| Pubmed | Expression of the NEK family in normal and cancer tissue: an immunohistochemical study. | 6.70e-05 | 4 | 117 | 2 | 31906878 | |
| Pubmed | 6.70e-05 | 4 | 117 | 2 | 24637776 | ||
| Pubmed | Distribution of centromeric proteins and PARP-1 during mitosis and apoptosis. | 6.70e-05 | 4 | 117 | 2 | 19723035 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | EDC3 RPS9 TSC1 HEATR1 ARHGAP35 NEK1 TRAP1 DST MTHFD1 SEC23IP TXNDC9 PCNT | 7.60e-05 | 934 | 117 | 12 | 33916271 |
| Pubmed | 7.87e-05 | 209 | 117 | 6 | 36779422 | ||
| Pubmed | Mammalian centromeres: DNA sequence, protein composition, and role in cell cycle progression. | 1.11e-04 | 5 | 117 | 2 | 9925740 | |
| Pubmed | 1.45e-04 | 708 | 117 | 10 | 39231216 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | EDC3 CENPE PPFIBP1 TSC1 ECPAS CCDC57 STXBP2 VPS33B NINL LRRCC1 PCNT | 1.48e-04 | 853 | 117 | 11 | 28718761 |
| Pubmed | Receptor-mediated clustering of FIP200 bypasses the role of LC3 lipidation in autophagy. | 1.56e-04 | 454 | 117 | 8 | 33226137 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | PLK2 EDC3 SETX PPFIBP1 NEK1 DST FAM13A CCSER2 MTCL1 RAPGEF2 GOLGA4 | 1.61e-04 | 861 | 117 | 11 | 36931259 |
| Pubmed | 1.67e-04 | 6 | 117 | 2 | 25877867 | ||
| Pubmed | 1.67e-04 | 6 | 117 | 2 | 11084331 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 1.74e-04 | 588 | 117 | 9 | 38580884 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | PDS5B CAD CENPF RPS9 HEATR1 TRRAP TRAP1 DST STXBP2 MTHFD1 GLE1 PCNT | 1.79e-04 | 1024 | 117 | 12 | 24711643 |
| Pubmed | Specification of kinetochore-forming chromatin by the histone H3 variant CENP-A. | 2.33e-04 | 7 | 117 | 2 | 11682612 | |
| Pubmed | Systematic discovery of nonobvious human disease models through orthologous phenotypes. | 2.33e-04 | 7 | 117 | 2 | 20308572 | |
| Pubmed | 2.33e-04 | 7 | 117 | 2 | 17376975 | ||
| Pubmed | 2.33e-04 | 7 | 117 | 2 | 22798074 | ||
| Pubmed | The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA. | 2.69e-04 | 262 | 117 | 6 | 36880596 | |
| Pubmed | Exploration of the cell-cycle genes found within the RIKEN FANTOM2 data set. | 3.10e-04 | 8 | 117 | 2 | 12819135 | |
| Pubmed | Generation of an integrated transcription map of the BRCA2 region on chromosome 13q12-q13. | 3.10e-04 | 8 | 117 | 2 | 8812419 | |
| Pubmed | 3.10e-04 | 8 | 117 | 2 | 23178929 | ||
| Pubmed | 3.10e-04 | 8 | 117 | 2 | 24282027 | ||
| Pubmed | 3.10e-04 | 39 | 117 | 3 | 25859222 | ||
| Pubmed | 3.17e-04 | 638 | 117 | 9 | 31182584 | ||
| Pubmed | Identification of host proteins required for HIV infection through a functional genomic screen. | 3.28e-04 | 272 | 117 | 6 | 18187620 | |
| Pubmed | CAD MYO7A SPTA1 RPS9 RTN3 TSC1 ARHGAP35 ARID1A OPA1 DST MTHFD1 LRRCC1 RAPGEF2 CDK5 | 3.30e-04 | 1431 | 117 | 14 | 37142655 | |
| Pubmed | 3.55e-04 | 513 | 117 | 8 | 25798074 | ||
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | PDS5B NRBP1 EDC3 PPFIBP1 RPS9 TSC1 RO60 HEATR1 ECPAS TRRAP OPA1 ZBTB24 MTHFD1 | 3.94e-04 | 1284 | 117 | 13 | 17353931 |
| Pubmed | 3.98e-04 | 9 | 117 | 2 | 17436311 | ||
| Pubmed | 4.01e-04 | 102 | 117 | 4 | 10231032 | ||
| Pubmed | 4.44e-04 | 44 | 117 | 3 | 26471122 | ||
| Pubmed | Comprehensive proteomic analysis of interphase and mitotic 14-3-3-binding proteins. | 4.72e-04 | 190 | 117 | 5 | 15161933 | |
| Pubmed | 4.76e-04 | 408 | 117 | 7 | 33766124 | ||
| Pubmed | Postnatal refinement of auditory hair cell planar polarity deficits occurs in the absence of Vangl2. | 4.96e-04 | 10 | 117 | 2 | 23986237 | |
| Pubmed | 4.96e-04 | 10 | 117 | 2 | 17363140 | ||
| Pubmed | 4.96e-04 | 10 | 117 | 2 | 29891719 | ||
| Pubmed | 5.52e-04 | 689 | 117 | 9 | 36543142 | ||
| Pubmed | 5.55e-04 | 549 | 117 | 8 | 38280479 | ||
| Pubmed | Identification of DeltaNp63alpha protein interactions by mass spectrometry. | 5.75e-04 | 48 | 117 | 3 | 20085233 | |
| Pubmed | 6.00e-04 | 305 | 117 | 6 | 21244100 | ||
| Pubmed | LIS1 regulates CNS lamination by interacting with mNudE, a central component of the centrosome. | 6.05e-04 | 11 | 117 | 2 | 11163258 | |
| Pubmed | 6.10e-04 | 114 | 117 | 4 | 21150319 | ||
| Pubmed | 6.11e-04 | 49 | 117 | 3 | 19019082 | ||
| Pubmed | 6.32e-04 | 560 | 117 | 8 | 35241646 | ||
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | 6.43e-04 | 704 | 117 | 9 | 29955894 | |
| Pubmed | The human TAS2R16 receptor mediates bitter taste in response to beta-glucopyranosides. | 7.24e-04 | 12 | 117 | 2 | 12379855 | |
| Pubmed | A new meiosis-specific cohesin complex implicated in the cohesin code for homologous pairing. | 7.24e-04 | 12 | 117 | 2 | 21274006 | |
| Pubmed | Identification and characterization of the potential promoter regions of 1031 kinds of human genes. | 7.27e-04 | 52 | 117 | 3 | 11337467 | |
| Pubmed | 7.41e-04 | 210 | 117 | 5 | 16565220 | ||
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | PDS5B PPFIBP1 APTX NMRAL1 TRRAP SEC23IP OASL GOLGA4 PPP1R16A | 7.46e-04 | 719 | 117 | 9 | 35337019 |
| Pubmed | NCOA2 CENPE LRRK2 HEATR1 ARMCX2 OPA1 ZNF182 SEPSECS LTN1 RAPGEF2 MCUB PPP1R16A | 8.25e-04 | 1215 | 117 | 12 | 15146197 | |
| Pubmed | 8.54e-04 | 13 | 117 | 2 | 15938754 | ||
| Pubmed | 8.59e-04 | 217 | 117 | 5 | 30619736 | ||
| Pubmed | 9.31e-04 | 332 | 117 | 6 | 37433992 | ||
| Pubmed | 9.94e-04 | 14 | 117 | 2 | 17108173 | ||
| Pubmed | 9.94e-04 | 14 | 117 | 2 | 26553929 | ||
| Pubmed | Enoyl-CoA hydratase-1 regulates mTOR signaling and apoptosis by sensing nutrients. | 9.94e-04 | 14 | 117 | 2 | 28878358 | |
| Pubmed | 1.03e-03 | 131 | 117 | 4 | 28031328 | ||
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | 1.04e-03 | 754 | 117 | 9 | 33060197 | |
| Pubmed | 1.08e-03 | 469 | 117 | 7 | 27634302 | ||
| Pubmed | 1.10e-03 | 60 | 117 | 3 | 26472337 | ||
| Interaction | GAN interactions | 1.29e-05 | 253 | 113 | 9 | int:GAN | |
| Interaction | YWHAB interactions | NRBP1 EDC3 CENPE PPFIBP1 LRRK2 RTN3 TSC1 TRRAP NEK1 DST FAM13A VPS33B CCSER2 NINL MTCL1 RAPGEF2 MAPK7 PDE7B | 1.34e-05 | 1014 | 113 | 18 | int:YWHAB |
| Interaction | RNF123 interactions | EDC3 SETX TBC1D30 CENPE CENPF MYO7A RPS9 LCA5L ZBTB41 ECPAS JAK2 FRY DST MTHFD1 ZNF408 MTCL1 | 1.43e-05 | 824 | 113 | 16 | int:RNF123 |
| Interaction | GPR17 interactions | 3.12e-05 | 283 | 113 | 9 | int:GPR17 | |
| GeneFamily | Taste 2 receptors | 1.71e-05 | 39 | 72 | 4 | 1162 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | NCOA2 PDS5B SETX CENPC CENPE CENPF ARHGAP35 TRRAP OPA1 NEK1 DST LTN1 CCSER2 MTCL1 WDFY3 RAPGEF2 GOLGA4 PCNT | 2.74e-08 | 856 | 113 | 18 | M4500 |
| Coexpression | GSE4984_LPS_VS_VEHICLE_CTRL_TREATED_DC_DN | 2.48e-05 | 198 | 113 | 7 | M6511 | |
| Coexpression | GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4HIGH_BCELL_DN | 2.64e-05 | 200 | 113 | 7 | M9839 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 4.85e-05 | 300 | 113 | 8 | M8702 | |
| Coexpression | BROWNE_HCMV_INFECTION_2HR_DN | 5.50e-05 | 48 | 113 | 4 | M521 | |
| Coexpression | GSE6259_DEC205_POS_DC_VS_BCELL_DN | 1.03e-04 | 172 | 113 | 6 | M6772 | |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 1.21e-04 | 177 | 113 | 6 | M39245 | |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_UP | 1.43e-04 | 448 | 113 | 9 | MM1044 | |
| Coexpression | LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q | 1.49e-04 | 116 | 113 | 5 | M8411 | |
| Coexpression | BILBAN_B_CLL_LPL_UP | 1.70e-04 | 64 | 113 | 4 | M19930 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 1.92e-04 | 466 | 113 | 9 | M13522 | |
| Coexpression | MEK_UP.V1_DN | 1.99e-04 | 194 | 113 | 6 | M2724 | |
| Coexpression | GSE37533_PPARG2_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_DN | 2.23e-04 | 198 | 113 | 6 | M8969 | |
| Coexpression | GSE12845_NAIVE_VS_DARKZONE_GC_TONSIL_BCELL_UP | 2.23e-04 | 198 | 113 | 6 | M3200 | |
| Coexpression | GSE9988_LPS_VS_LPS_AND_ANTI_TREM1_MONOCYTE_UP | 2.23e-04 | 198 | 113 | 6 | M5856 | |
| Coexpression | GSE3982_NEUTROPHIL_VS_TH2_DN | 2.23e-04 | 198 | 113 | 6 | M5535 | |
| Coexpression | GSE3982_CTRL_VS_LPS_4H_MAC_DN | 2.29e-04 | 199 | 113 | 6 | M5368 | |
| Coexpression | GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_DC_DN | 2.29e-04 | 199 | 113 | 6 | M5206 | |
| Coexpression | GSE7548_NAIVE_VS_DAY7_PCC_IMMUNIZATION_CD4_TCELL_DN | 2.29e-04 | 199 | 113 | 6 | M6837 | |
| Coexpression | GSE7460_TREG_VS_TCONV_ACT_WITH_TGFB_UP | 2.29e-04 | 199 | 113 | 6 | M5692 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | SETX GALNT3 TSC1 RO60 ECPAS LRRC8D OPA1 JAK2 FAM13A LTN1 PPP1R16B ZNF814 RAPGEF2 MCUB GOLGA4 | 2.30e-04 | 1215 | 113 | 15 | M41122 |
| Coexpression | HOWARD_PBMC_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_19_39YO_AS03_ADJUVANT_VS_BUFFER_1DY_UP | 2.34e-04 | 377 | 113 | 8 | M40997 | |
| Coexpression | GSE339_EX_VIVO_VS_IN_CULTURE_CD4POS_DC_DN | 2.35e-04 | 200 | 113 | 6 | M5130 | |
| Coexpression | GSE8835_HEALTHY_VS_CLL_CD8_TCELL_DN | 2.35e-04 | 200 | 113 | 6 | M6263 | |
| Coexpression | GSE22886_TH1_VS_TH2_48H_ACT_DN | 2.35e-04 | 200 | 113 | 6 | M4512 | |
| Coexpression | GSE13306_RA_VS_UNTREATED_TREG_UP | 2.35e-04 | 200 | 113 | 6 | M3232 | |
| Coexpression | GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_UP | 2.35e-04 | 200 | 113 | 6 | M3580 | |
| Coexpression | GSE17721_CTRL_VS_PAM3CSK4_6H_BMDC_DN | 2.35e-04 | 200 | 113 | 6 | M3742 | |
| Coexpression | GSE33424_CD161_INT_VS_NEG_CD8_TCELL_UP | 2.35e-04 | 200 | 113 | 6 | M8554 | |
| Coexpression | GSE18893_TCONV_VS_TREG_24H_CULTURE_DN | 2.35e-04 | 200 | 113 | 6 | M7289 | |
| Coexpression | GSE26343_UNSTIM_VS_LPS_STIM_NFAT5_KO_MACROPHAGE_DN | 2.35e-04 | 200 | 113 | 6 | M8643 | |
| Coexpression | GSE21774_CD62L_POS_CD56_BRIGHT_VS_CD62L_NEG_CD56_DIM_NK_CELL_DN | 2.35e-04 | 200 | 113 | 6 | M7495 | |
| Coexpression | GSE21546_SAP1A_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP | 2.35e-04 | 200 | 113 | 6 | M7525 | |
| Coexpression | GSE10239_MEMORY_VS_KLRG1HIGH_EFF_CD8_TCELL_DN | 2.35e-04 | 200 | 113 | 6 | M3067 | |
| Coexpression | FISCHER_DREAM_TARGETS | PDS5B CAD CENPC CENPE CENPF HEATR1 MND1 OPA1 LRR1 MTHFD1 ZNF92 LRRCC1 PCNT | 2.81e-04 | 969 | 113 | 13 | M149 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | PDS5B CENPE CENPF RTN3 NFKBIZ ARHGAP35 ECPAS ARID1A MAP3K12 NEK1 UBR3 WDFY3 RAPGEF2 | 1.87e-05 | 629 | 108 | 13 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| ToppCell | droplet-Skin-nan-18m-Epithelial-stem_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-07 | 165 | 115 | 7 | 96f0d8bc9b13e23f757e6bb98cd7dc061a8a9564 | |
| ToppCell | control-Neutrophil|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.02e-07 | 200 | 115 | 7 | b5d197472799cc61d7497faed91ac2564ae4930a | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.13e-06 | 130 | 115 | 6 | 92913960e4367261ba08a405b61a421bc5e18169 | |
| ToppCell | Control-Myeloid-Mast|World / Disease state, Lineage and Cell class | 5.51e-06 | 171 | 115 | 6 | ed8e61d524f4cddc6084b261175df54d2a64a60f | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.38e-06 | 184 | 115 | 6 | a8c6028d745aaa6ee7842259238694cb50ce0526 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.38e-06 | 184 | 115 | 6 | 081d045f3bc98a36f342de7d50f39c9a888dd7eb | |
| ToppCell | Control-Myeloid_G-immature_Neutrophil|Control / Disease group, lineage and cell class | 8.38e-06 | 184 | 115 | 6 | 45f873236f7e90fb78c8e291d3b5b92d121acec9 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.38e-06 | 184 | 115 | 6 | 84c20730cd92b9aaa50077d7b625e37e7f9e91d2 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.38e-06 | 184 | 115 | 6 | d31d4116d1d196633784863781fa45673607a421 | |
| ToppCell | Control-immature_Neutrophil-|Control / Disease condition and Cell class | 8.38e-06 | 184 | 115 | 6 | c4e8ba82a6aa76c46f05a71d5f1c7926555318cf | |
| ToppCell | Control-immature_Neutrophil|Control / Disease condition and Cell class | 8.38e-06 | 184 | 115 | 6 | 2fdae5c6b3eb2232881d933a8c1061fda3623016 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.92e-06 | 186 | 115 | 6 | 4ae3c0fe8640a8d029875cf3f0f5ffbba38e85f8 | |
| ToppCell | systemic_lupus_erythematosus-flare-Myeloid-classical_monocyte-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 9.77e-06 | 189 | 115 | 6 | cce6602ad68c177985a5e43cfb2776d615cfbca0 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 9.77e-06 | 189 | 115 | 6 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | COVID-19-Myeloid-MoAM1,_IL1R2|Myeloid / Condition, Lineage and Cell class | 1.07e-05 | 192 | 115 | 6 | be9d5685fa03563322f147a4b38ed31e4da59487 | |
| ToppCell | erythropoietic-Basophilic_Erythroblast|World / Lineage and Cell class | 1.27e-05 | 198 | 115 | 6 | b3db4db02c0e659163cefb3d83f53e4940cc04bf | |
| ToppCell | systemic_lupus_erythematosus-treated-Myeloid|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.27e-05 | 198 | 115 | 6 | f37578f156e8aed2ce30cfa837ae04dd18de05d0 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.27e-05 | 198 | 115 | 6 | df546a9afc0e15398f33c1b511c7281771f9aea0 | |
| ToppCell | Control-Control-Myeloid-immature_Neutrophil|Control / Disease, condition lineage and cell class | 1.35e-05 | 200 | 115 | 6 | 118321ac443feb42aee171baccfc4610f00a8822 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-myeloid|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.35e-05 | 200 | 115 | 6 | 6da31ce0a70ad5621444d731c082c0db572c20c5 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.35e-05 | 200 | 115 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | erythropoietic-Polychromatic_Erythroblast|erythropoietic / Lineage and Cell class | 1.35e-05 | 200 | 115 | 6 | 27056f28328df2a51d5634a7927b7084241e3ca2 | |
| ToppCell | mild-CD163+_Monocytes_(Sample_ID1_d7)|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.35e-05 | 200 | 115 | 6 | 99eb02f974ddc8d1882f4a5b34d4503d6ec0a5f5 | |
| ToppCell | COVID-19-kidney-Lymphatic_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.13e-05 | 148 | 115 | 5 | f777aa1674e898e2594b2b7c029d3d05dda04df9 | |
| ToppCell | PND10-Immune-Immune_Myeloid-DC-cDC2-cDC2_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.53e-05 | 163 | 115 | 5 | 7af3d3ae7e0de733a18d0486c7ffbb5a7ef7230a | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic-Neutrophil-Neu_c5-GSTP1(high)OASL(low)|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.53e-05 | 163 | 115 | 5 | d005115aa1e1458b51de7eb719794617a4168608 | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_proliferating_2|390C / Donor, Lineage, Cell class and subclass (all cells) | 6.72e-05 | 164 | 115 | 5 | ad508f53009efdd1dae7abcdb5431387f3f7e7b2 | |
| ToppCell | severe-unassigned|World / disease stage, cell group and cell class | 6.72e-05 | 164 | 115 | 5 | b3a45c150df6594debeeca400cc58d30ef662756 | |
| ToppCell | severe-unassigned|severe / disease stage, cell group and cell class | 6.92e-05 | 165 | 115 | 5 | f9ddd547992fec065d539a1d0305acba8fc7d79c | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.92e-05 | 165 | 115 | 5 | 1dcd6b8aa192baeaa1f7bb334843edab6049b96f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_low-phase|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.12e-05 | 166 | 115 | 5 | 43f84d3cd58e93ce00c241656c4cba27604b4932 | |
| ToppCell | facs-Spleen-nan-24m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.33e-05 | 167 | 115 | 5 | 16bb7293fc8ca582b7cb4450917aff07b34fc70a | |
| ToppCell | facs-Spleen-nan-24m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.33e-05 | 167 | 115 | 5 | 515988c7035c550a2f072430d9d7027869593d17 | |
| ToppCell | COVID-19-kidney-Lymphatic_EC|kidney / Disease (COVID-19 only), tissue and cell type | 7.33e-05 | 167 | 115 | 5 | 97d0fea1f41c1c00e36d9b5c4c1f0dd85087056f | |
| ToppCell | facs-Spleen-nan-24m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.33e-05 | 167 | 115 | 5 | f12d00e6c600b0bba3e4e1b1c80b791e095de931 | |
| ToppCell | Control-Myeloid-Mast|Control / Disease state, Lineage and Cell class | 7.97e-05 | 170 | 115 | 5 | 9a14deb7f7cd4a49c217eba4023f7bf1dec6c902 | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-cDC2|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.97e-05 | 170 | 115 | 5 | 9e94fa0d05abed3438b28296a293767096d517d6 | |
| ToppCell | droplet-Kidney-nan-24m-Lymphocytic-lymphocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.19e-05 | 171 | 115 | 5 | ff117bf1a0755aa7d7c3db29749a7b9b90cc0b2f | |
| ToppCell | Immune_cells-pro-B|Immune_cells / Lineage and Cell class | 8.42e-05 | 172 | 115 | 5 | 096636f2589fa56d15942aac96641c16fd5fa78d | |
| ToppCell | droplet-Kidney-nan-24m-Lymphocytic-CD45|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.42e-05 | 172 | 115 | 5 | 95219814e37259e34be053572cc95d4639360c27 | |
| ToppCell | droplet-Spleen-SPLEEN-30m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.42e-05 | 172 | 115 | 5 | 02cc4a9fb7902c572cee37ba828749db4913ee87 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Endothelial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.89e-05 | 174 | 115 | 5 | c58328c2f262506a4518f49f148e29874faf9171 | |
| ToppCell | Control-Myeloid-Mast|Myeloid / Disease state, Lineage and Cell class | 9.38e-05 | 176 | 115 | 5 | 0c5916d63e1ada09105e46d2429b75129b7329ec | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.38e-05 | 176 | 115 | 5 | 40993c41c1017b53039a337174fc56632b278609 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D231|Adult / Lineage, Cell type, age group and donor | 9.89e-05 | 178 | 115 | 5 | c80ca7a2d3f976089a5e71d0cd9ba9a1c0bd2815 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Cycling_Myeloid-Mac|lymph-node_spleen / Manually curated celltypes from each tissue | 1.04e-04 | 180 | 115 | 5 | 4eea8366cdb82c356325ce88f09ad8b302c17a07 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.10e-04 | 182 | 115 | 5 | 53c267ee327e116dbd89d5927ed3bdf78d25ee62 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.13e-04 | 183 | 115 | 5 | 4d16bfbadf2cd13008c35e23dd2b5b4ecf92ee11 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 1.13e-04 | 183 | 115 | 5 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | IPF-Myeloid-Mast|Myeloid / Disease state, Lineage and Cell class | 1.16e-04 | 184 | 115 | 5 | 7326a16d7d3ae41b8c9d2beaec7f977b374f3469 | |
| ToppCell | BAL-Severe-Myeloid-Macrophage|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.19e-04 | 185 | 115 | 5 | ae966929fb5bbb08ffcbac76cb21941638727f55 | |
| ToppCell | BAL-Severe-Myeloid-Macrophage-transitional_Macro-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.19e-04 | 185 | 115 | 5 | 3beebaa92275086b1fae5f8c0c3d54016c5ba2aa | |
| ToppCell | BAL-Severe-Myeloid-Macrophage-transitional_Macro-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.19e-04 | 185 | 115 | 5 | ceff11cfa679147ccfd0a0f8079e697a6bea34d9 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 185 | 115 | 5 | afbb88325e4a81c15ac1d0a004e3e1f4ba2ee87b | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 185 | 115 | 5 | 775b72319ef6acffd2c9a74293b9c1bccea33f42 | |
| ToppCell | BAL-Severe-Myeloid-Macrophage|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.19e-04 | 185 | 115 | 5 | 9aea5ed8f9cee5ee933891203aac7adb85d68201 | |
| ToppCell | BAL-Severe-Myeloid-Macrophage-transitional_Macro|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.19e-04 | 185 | 115 | 5 | 42939b294ea3e871274d8b73124c850dc1904fd2 | |
| ToppCell | Severe_COVID-19-Myeloid-transitional_Macro|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.19e-04 | 185 | 115 | 5 | f7ef0d7740b4cfedc38846e802898c402dc411fd | |
| ToppCell | BAL-Severe-Myeloid-Macrophage-transitional_Macro|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.19e-04 | 185 | 115 | 5 | 7a3612520ae4f0cd61480eadba31eecce001419d | |
| ToppCell | COPD-Myeloid-Mast|COPD / Disease state, Lineage and Cell class | 1.22e-04 | 186 | 115 | 5 | def6f0f284acc2154738574c8c5d3d2a5ef1f208 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.22e-04 | 186 | 115 | 5 | 40070d9cd20188ba49b32acfca9bc16256b38bf5 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 186 | 115 | 5 | ac6e32cf07f0f013101ca7aedae0c562857f182b | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 186 | 115 | 5 | 7cdcf507a9a1349ed2cf62b79116367c3fc732dd | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_proliferating|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.22e-04 | 186 | 115 | 5 | 5d527050cd554cc46c6d8dcb7981900725d79fc6 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_proliferating-Lymphatic_EC_proliferating_L.2.5.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.22e-04 | 186 | 115 | 5 | ee1c3e2adfa2900542200a218746b576c7ed10dc | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 187 | 115 | 5 | dceca7ae3dae96078cccc17a0d8a61b06fa6dffb | |
| ToppCell | 343B-Lymphocytic-ILC-ILC-1|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.28e-04 | 188 | 115 | 5 | 8f6b45ad82bde65e044d17f0edbc3db90d457915 | |
| ToppCell | Endothelial-endothelial_cell_of_lymph_vessel|World / Lineage, Cell type, age group and donor | 1.28e-04 | 188 | 115 | 5 | 80910dcbb51990f2baed240f319456c0d3fa2065 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.28e-04 | 188 | 115 | 5 | 2db80767903703e7e0a1a37c598f7877a909ee94 | |
| ToppCell | NS-critical-d_0-4-Lymphoid-NKT-proliferating|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.31e-04 | 189 | 115 | 5 | d6bd46abb072b13a6b72f1ca25d19f218cceb1ff | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.31e-04 | 189 | 115 | 5 | 0d18ea72bd58d32a8ab9a61cf97f5786642f804b | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.31e-04 | 189 | 115 | 5 | 55a1776a4ce049959b3f13a43744c7314bc1f00a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-04 | 189 | 115 | 5 | bd91bdfe35294e60d980259b70fe9e60dca2743f | |
| ToppCell | COPD-Myeloid-Mast|Myeloid / Disease state, Lineage and Cell class | 1.34e-04 | 190 | 115 | 5 | 379dbac19110b76079a7a53209569e060a852acb | |
| ToppCell | IPF-Myeloid-cMonocyte|World / Disease state, Lineage and Cell class | 1.34e-04 | 190 | 115 | 5 | ffa890138394f579fee53fcfac6c121bf86adc26 | |
| ToppCell | Leuk-UTI-Myeloid-CD14_Mono|Leuk-UTI / Disease, Lineage and Cell Type | 1.44e-04 | 193 | 115 | 5 | d1eac8627d00629ed2e81d3b86778007304efcb7 | |
| ToppCell | Megakaryocytic-erythropoietic-Erythro-cells-Polychromatic_Erythroblast|World / Lineage, cell class and subclass | 1.48e-04 | 194 | 115 | 5 | 008bb0072f414a48d052429101bdc990ee4f80c2 | |
| ToppCell | COPD-Endothelial-Lymphatic|Endothelial / Disease state, Lineage and Cell class | 1.52e-04 | 195 | 115 | 5 | e91ce548ae7224661ee5d2f2639794a5f69798ee | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.52e-04 | 195 | 115 | 5 | 9f7dc9328d244291baf92b03c346c2189b58e7c4 | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 1.52e-04 | 195 | 115 | 5 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | NS-moderate-d_16-33-Myeloid-Monocyte-derived_Macrophage|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.52e-04 | 195 | 115 | 5 | d87c83d2d421c9291d0a10bc9db850e9fb337667 | |
| ToppCell | Control-Neu_4|Control / 5 Neutrophil clusters in COVID-19 patients | 1.55e-04 | 196 | 115 | 5 | b8b7b54ca17a08fa775507bb22b1c7248ada8f40 | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-B-Plasmablast|Int-URO / Disease, condition lineage and cell class | 1.55e-04 | 196 | 115 | 5 | e65b47d0ce1a5dd05f5f50e1639c8ec76fb42dc8 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c12-MKI67-TYROBP|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.55e-04 | 196 | 115 | 5 | f70a2b227716a0df3c1aa6a414b822e63f209a43 | |
| ToppCell | BL-critical-LOC-Myeloid-Neutrophil|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.55e-04 | 196 | 115 | 5 | f64d7fed31e418c55fe946744d78c3cbecec9bbf | |
| ToppCell | Control-Endothelial-Lymphatic|Endothelial / Disease state, Lineage and Cell class | 1.55e-04 | 196 | 115 | 5 | e0cf617b0f5d9c3c19574f587a3d0ccbf93d8ca4 | |
| ToppCell | distal-Endothelial-Lymphatic-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.55e-04 | 196 | 115 | 5 | b0f23dc802a2c2a56a08d398a464ea78b58ade4c | |
| ToppCell | (000)_CD14+_Monocyte|World / immune cells in Peripheral Blood (logTPM normalization) | 1.59e-04 | 197 | 115 | 5 | cff498bc7b153f28dd013eaeb73ead4fb62fb44c | |
| ToppCell | ICU-SEP-Myeloid-CD14_Mono|ICU-SEP / Disease, Lineage and Cell Type | 1.59e-04 | 197 | 115 | 5 | fd08bb4fe521d758c99b3f2533570739a920e99c | |
| ToppCell | COVID-19_Severe-T/NK_proliferative|COVID-19_Severe / Disease condition and Cell class | 1.59e-04 | 197 | 115 | 5 | 718a84e9a8248080f2d964e7c6a3ba183ece9592 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Monocytic-Classical_Monocyte|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.59e-04 | 197 | 115 | 5 | 2afc23f7394d9b40bdf06527c5e6b553e1b02dca | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Myeloid-Monocytic-Classical_Monocyte|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.59e-04 | 197 | 115 | 5 | 0050da0d809075fde3a7f17894dbb410b254988c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.59e-04 | 197 | 115 | 5 | 15bcfe6105c0b508811fb9bba0bc4312fea04f4c | |
| ToppCell | erythropoietic-Polychromatic_Erythroblast|World / Lineage and Cell class | 1.59e-04 | 197 | 115 | 5 | 604fcbf47f073c2af344e1b16b615a78ef838dc9 | |
| ToppCell | normal-na-Myeloid-classical_monocyte-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.63e-04 | 198 | 115 | 5 | 58aa5041077fe17ca01c5e6da077d8008d5123ab | |
| ToppCell | (00)_Monocyte|World / immune cells in Peripheral Blood (logTPM normalization) | 1.63e-04 | 198 | 115 | 5 | 2252e756a8a25d32c16a723e833c1390a772c2a4 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.63e-04 | 198 | 115 | 5 | 110f7ebb3e1ec19508d4d2b973e1f64e7bdbb5b5 | |
| ToppCell | systemic_lupus_erythematosus-treated-Myeloid-classical_monocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.63e-04 | 198 | 115 | 5 | c79c1738560d78b63dbed5f2f9621dbc1c2363cb | |
| ToppCell | PBMC-Convalescent-Myeloid|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.63e-04 | 198 | 115 | 5 | 3973bbc1bfb5b08dd1becd5e4bb5899b15df9e55 | |
| ToppCell | systemic_lupus_erythematosus-treated-Myeloid-classical_monocyte|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.63e-04 | 198 | 115 | 5 | 1d1c80569f1e307285ba0ebaf5c72e0b5b538864 | |
| Drug | Ricinine [524-40-3]; Down 200; 24.4uM; HL60; HT_HG-U133A | KANSL1L TBC1D30 CENPF PPFIBP1 ARHGAP35 FAM13A ZNF408 OASL WDFY3 | 5.24e-07 | 193 | 113 | 9 | 2505_DN |
| Drug | Ceftazidime pentahydrate [78439-06-2]; Down 200; 6.2uM; PC3; HT_HG-U133A | 6.77e-07 | 199 | 113 | 9 | 5054_DN | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 2.56e-06 | 174 | 113 | 8 | 7530_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 3.58e-06 | 182 | 113 | 8 | 3887_DN | |
| Drug | GW8510; Down 200; 10uM; MCF7; HT_HG-U133A | 4.37e-06 | 187 | 113 | 8 | 7080_DN | |
| Drug | Tracazolate hydrochloride [41094-88-6]; Down 200; 11.8uM; HL60; HT_HG-U133A | 5.31e-06 | 192 | 113 | 8 | 2919_DN | |
| Drug | Bephenium hydroxynaphthoate [3818-50-6]; Down 200; 9uM; MCF7; HT_HG-U133A | 5.52e-06 | 193 | 113 | 8 | 5628_DN | |
| Drug | Etofenamate [30544-47-9]; Down 200; 10.8uM; HL60; HT_HG-U133A | 6.18e-06 | 196 | 113 | 8 | 2907_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.05e-05 | 178 | 113 | 7 | 1672_DN | |
| Drug | Digitoxigenin [143-62-4]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 3.40e-05 | 181 | 113 | 7 | 3275_DN | |
| Drug | Digoxin [20830-75-5]; Down 200; 5.2uM; MCF7; HT_HG-U133A | 3.52e-05 | 182 | 113 | 7 | 5324_DN | |
| Drug | GW8510; Down 200; 10uM; MCF7; HT_HG-U133A | 3.64e-05 | 183 | 113 | 7 | 7062_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 3.77e-05 | 184 | 113 | 7 | 2321_DN | |
| Drug | Apigenin [520-36-5]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 4.32e-05 | 188 | 113 | 7 | 3257_DN | |
| Drug | Primaquine diphosphate [63-45-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 4.32e-05 | 188 | 113 | 7 | 4845_DN | |
| Drug | Luteolin [491-70-3]; Down 200; 14uM; MCF7; HT_HG-U133A | 4.62e-05 | 190 | 113 | 7 | 3379_DN | |
| Drug | Strophantine octahydrate [11018-89-6]; Down 200; 5.4uM; PC3; HT_HG-U133A | 4.62e-05 | 190 | 113 | 7 | 6680_DN | |
| Drug | Mesalamine [89-57-6]; Down 200; 26.2uM; HL60; HT_HG-U133A | 4.94e-05 | 192 | 113 | 7 | 6162_DN | |
| Drug | Roxarsone [121-19-7]; Down 200; 15.2uM; PC3; HT_HG-U133A | 5.28e-05 | 194 | 113 | 7 | 5051_DN | |
| Drug | Dobutamine hydrochloride [49745-95-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 5.45e-05 | 195 | 113 | 7 | 5386_UP | |
| Drug | Isradipine [75695-93-1]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 5.45e-05 | 195 | 113 | 7 | 5447_DN | |
| Drug | Cefamandole sodium salt [30034-03-8]; Down 200; 8.2uM; PC3; HT_HG-U133A | 5.45e-05 | 195 | 113 | 7 | 7394_DN | |
| Drug | Apomorphine hydrochloride hemihydrate [41372-20-7]; Down 200; 6.4uM; HL60; HG-U133A | 5.63e-05 | 196 | 113 | 7 | 2005_DN | |
| Drug | Metampicillin sodium salt [6489-61-8]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 5.63e-05 | 196 | 113 | 7 | 5540_DN | |
| Drug | Azaperone [1649-18-9]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 5.81e-05 | 197 | 113 | 7 | 7231_DN | |
| Drug | Myricetin [529-44-2]; Down 200; 12.6uM; PC3; HT_HG-U133A | 6.00e-05 | 198 | 113 | 7 | 4090_DN | |
| Drug | Althiazide [5588-16-9]; Up 200; 10.4uM; PC3; HT_HG-U133A | 6.00e-05 | 198 | 113 | 7 | 4491_UP | |
| Drug | Chlorpheniramine maleate [113-92-8]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 6.00e-05 | 198 | 113 | 7 | 2217_DN | |
| Drug | Ranitidine hydrochloride [66357-59-3]; Up 200; 11.4uM; PC3; HT_HG-U133A | 6.20e-05 | 199 | 113 | 7 | 6324_UP | |
| Drug | Iobenguane sulfate; Up 200; 10.8uM; HL60; HG-U133A | 6.20e-05 | 199 | 113 | 7 | 1729_UP | |
| Drug | Trimethoprim [738-70-5]; Down 200; 13.8uM; PC3; HT_HG-U133A | 6.20e-05 | 199 | 113 | 7 | 3678_DN | |
| Drug | Cinnarizine [298-57-7]; Down 200; 10.8uM; PC3; HT_HG-U133A | 6.20e-05 | 199 | 113 | 7 | 5817_DN | |
| Drug | Ozagrel hydrochloride [78712-43-3]; Up 200; 15.2uM; MCF7; HT_HG-U133A | 6.39e-05 | 200 | 113 | 7 | 3503_UP | |
| Drug | Sulfapyridine [144-83-2]; Down 200; 16uM; PC3; HT_HG-U133A | 6.39e-05 | 200 | 113 | 7 | 7151_DN | |
| Drug | Butamben [94-25-7]; Up 200; 20.6uM; MCF7; HT_HG-U133A | 6.39e-05 | 200 | 113 | 7 | 6266_UP | |
| Drug | CHDM | 7.30e-05 | 3 | 113 | 2 | CID000007735 | |
| Drug | Wang resin | 7.30e-05 | 3 | 113 | 2 | CID000070043 | |
| Drug | Antigens, Polyomavirus Transforming | NCOA2 SETX CENPF RPS9 NFKBIZ TSC1 ARID1A MAP3K12 OPA1 GLE1 LTN1 PRKX | 1.22e-04 | 668 | 113 | 12 | ctd:D000952 |
| Disease | SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1 | 4.20e-05 | 3 | 111 | 2 | C1853761 | |
| Disease | Chronic myeloproliferative disorder | 4.80e-05 | 19 | 111 | 3 | C1292778 | |
| Disease | Amyotrophic Lateral Sclerosis | 6.88e-05 | 58 | 111 | 4 | C0002736 | |
| Disease | Seckel syndrome | 7.57e-05 | 22 | 111 | 3 | C0265202 | |
| Disease | Ovarian Serous Adenocarcinoma | 8.69e-05 | 23 | 111 | 3 | C1335177 | |
| Disease | Ovarian Mucinous Adenocarcinoma | 2.16e-04 | 31 | 111 | 3 | C1335167 | |
| Disease | Hereditary spherocytosis | 3.87e-04 | 8 | 111 | 2 | C0037889 | |
| Disease | thrombosis (implicated_via_orthology) | 6.19e-04 | 10 | 111 | 2 | DOID:0060903 (implicated_via_orthology) | |
| Disease | Ciliopathies | 8.06e-04 | 110 | 111 | 4 | C4277690 | |
| Disease | Hematologic Neoplasms | 9.03e-04 | 12 | 111 | 2 | C0376545 | |
| Disease | Cakut | 1.06e-03 | 13 | 111 | 2 | C1968949 | |
| Disease | quinate measurement | 1.43e-03 | 15 | 111 | 2 | EFO_0021167 | |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 1.63e-03 | 16 | 111 | 2 | DOID:0110861 (implicated_via_orthology) | |
| Disease | Hereditary Non-Polyposis Colon Cancer Type 2 | 2.30e-03 | 19 | 111 | 2 | C1333991 | |
| Disease | Colorectal cancer, hereditary nonpolyposis, type 1 | 2.30e-03 | 19 | 111 | 2 | C2936783 | |
| Disease | Prostatic Neoplasms | 2.32e-03 | 616 | 111 | 8 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 2.32e-03 | 616 | 111 | 8 | C0376358 | |
| Disease | sphingomyelin 22:0 measurement | 2.55e-03 | 20 | 111 | 2 | EFO_0010395 | |
| Disease | Down syndrome (is_marker_for) | 3.08e-03 | 22 | 111 | 2 | DOID:14250 (is_marker_for) | |
| Disease | response to clopidogrel, cardiovascular event measurement | 3.37e-03 | 23 | 111 | 2 | EFO_0006919, GO_1903493 | |
| Disease | squamous cell lung carcinoma | 3.55e-03 | 165 | 111 | 4 | EFO_0000708 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ERHQLKTKVVHLSKL | 466 | Q6ZN18 | |
| KQIKAKHTLLRHEGI | 21 | Q96BT7 | |
| KELKHKNIVRLHDVL | 56 | Q00535 | |
| KNIVRLHDVLHSDKK | 61 | Q00535 | |
| ALVLTLLLKKHTHQK | 101 | Q07092 | |
| ILREHLKEEKLHAKK | 121 | Q9H175 | |
| IKETVHKLLRRLHLM | 2366 | Q86UK0 | |
| SLKAVAREHLELLKH | 226 | Q7Z2E3 | |
| KAEHRHRAKILNLKL | 206 | Q53GS7 | |
| RLSVLLGLKKKEVHV | 6 | Q9H0F7 | |
| TAHLHRDKALLKRLL | 386 | Q8NEG7 | |
| HHDLLVKVKVIKLVN | 616 | Q7L311 | |
| IRSALLPVLHHKSKK | 706 | Q9NTI5 | |
| LQKHKERIDHIKLLQ | 941 | O60674 | |
| KVAKDVSVRLHHELK | 426 | Q9Y4B5 | |
| KISLKHELFRHGILL | 536 | Q6ZRR7 | |
| IIVRLHETLFKTKKL | 796 | O94822 | |
| LGKLILLHHKHPERK | 2011 | O14497 | |
| RELKILKHFKHDNII | 101 | Q13164 | |
| HARLLHCVSKQKILL | 221 | A0AUZ9 | |
| KELLLHIRSHKQKAS | 121 | Q9BYH8 | |
| AKLCKRRIEHLKEHS | 96 | Q7L5Y9 | |
| QKKREHHLLEKIDHL | 181 | Q9NWR8 | |
| ALLTKHTRKVVHDAK | 226 | Q9HBL8 | |
| QICLALKHVHDRKIL | 111 | Q96PY6 | |
| LKHVHDRKILHRDIK | 116 | Q96PY6 | |
| LKSLRKLDLSHNHIK | 176 | Q96L50 | |
| LEKELGIKHSLHRKK | 686 | Q86W92 | |
| GIKHSLHRKKLQLAL | 691 | Q86W92 | |
| LKVVSVLHHLSIKRA | 761 | Q86W92 | |
| LELLLKERDKHLKEH | 761 | Q13439 | |
| HKKHLEVLHSLLKEI | 4316 | Q03001 | |
| LLSLVRKLSTHKEVK | 966 | Q5VYK3 | |
| ALKHTIKLLTVIKWH | 526 | Q9NZN1 | |
| KRLVLRTKLHKLIDF | 256 | Q9UHC1 | |
| SKALHARKHKLEVLE | 76 | Q9BWT6 | |
| LTRLKAHLHNKDLRL | 291 | Q9NP56 | |
| LKHIHDRKILHRDIK | 116 | Q6P3R8 | |
| EKLETTLRHKHLAFL | 771 | Q6ZU69 | |
| HILTKLNFHLRKKVL | 886 | Q6ZU69 | |
| EKLETTLRHKHLAFL | 501 | Q63HN1 | |
| HKTAVLLTELKTKLH | 66 | Q5VZ66 | |
| RVEKLHLSHNKLKEI | 1246 | Q5S007 | |
| HRILSARLHKIKGLK | 141 | O95447 | |
| LLREHERLLKHKLKV | 556 | Q96PP9 | |
| IKVNSFKHLRHLEIL | 91 | Q9HCJ2 | |
| LHKKLLSVAEKHGLT | 286 | Q96F86 | |
| HIKAKLRLLEVLISK | 1001 | O94988 | |
| RAVSKLEKLLKHHLQ | 3071 | O95613 | |
| HLTLLLKLEDKLNRH | 461 | Q9UHY1 | |
| HRPTKLKSLLRLVKH | 201 | Q15646 | |
| EFKVLLLELKHKHDV | 306 | Q96T49 | |
| DDKGIHHRKLKKSLI | 251 | O60313 | |
| KTQLLKLKRLLHQHD | 676 | Q9H7U1 | |
| LRLHEAEKKHQALLL | 2701 | P49454 | |
| SKVIPKNRIHHKLVL | 716 | Q03188 | |
| MAHLKRLVKLHIKRH | 1 | Q14435 | |
| FRHLHLKLKRLKLEE | 46 | A0A1B0GU71 | |
| IRTLKHKFKTLEKHL | 586 | Q2TAC2 | |
| DLKETDIKHLRKLKH | 156 | Q12852 | |
| DIKHLRKLKHPNIIT | 161 | Q12852 | |
| SLKKHLHAEIKVIGT | 36 | Q9H2W1 | |
| IHKRKIIAVATLHKS | 101 | Q9P267 | |
| KLLELIGHAVAHLKK | 311 | P09913 | |
| KRHLEAILTKISLKN | 376 | Q9H583 | |
| EVFEHSKKLLLHLLI | 1681 | Q5TBA9 | |
| ITLKGKKSLFRHLLH | 3811 | Q8NDH2 | |
| HSIRKLQAHVLLIKA | 231 | Q9H4I8 | |
| TKAKVLLSALERLKH | 351 | P11586 | |
| LQTKEELKIAHIHLK | 1231 | Q02224 | |
| ELRHLKILHVKSNLT | 586 | Q7L1W4 | |
| EAVKKVLSRHLHLLK | 331 | Q8NGV5 | |
| LLIHHLCINRKKVSL | 11 | Q8NH67 | |
| KLGLAKSIHHARVLI | 116 | P46781 | |
| KTELVKKHVLARLLT | 826 | O95197 | |
| LISLHLKKRIKSVVL | 116 | P59542 | |
| LIFHHLKRKAKSVVL | 116 | P59543 | |
| LIFLHLKKRIKSVVL | 116 | P0DSN6 | |
| LIFHHLKRKAKSVVL | 116 | P0DTE0 | |
| LKKKGKEIFHRLHLS | 201 | P0CI25 | |
| KKTVLHKELVIHILD | 621 | O60522 | |
| KSLLHLKTIRHKLLP | 151 | P27169 | |
| KAAIDHLHQKILKIT | 286 | O75069 | |
| KKRVITLRKSLLVHH | 341 | Q92901 | |
| KKHVRKLHDSSLGLA | 416 | A0PJY2 | |
| RAKLLELKHKHDALL | 311 | Q96I34 | |
| LSHVIKKQHRKSTLV | 791 | Q7Z333 | |
| LKAVLIPHHKGRKRL | 841 | Q9Y6Y8 | |
| KLLHLEDVVRALEKH | 1061 | Q9Y2I6 | |
| EKLLKKARIHPFHIL | 311 | P10155 | |
| KAKKLFLQHIHRLKH | 316 | Q9NRY4 | |
| RVALAKDHLKQIKEH | 211 | Q0VFZ6 | |
| KALKVALSHHLVARV | 1141 | O75153 | |
| TSLKEKHKILHRLLQ | 681 | Q15596 | |
| KIIKHFIKIALHCRE | 786 | Q9Y4G8 | |
| KHVNLLHIESRKSKR | 41 | P17752 | |
| LLEVKLTLLHVLHKF | 486 | P24557 | |
| AHHFVIRKTEELLKK | 616 | Q92574 | |
| KSKLIIHQRIHTGEK | 526 | P17025 | |
| AFRVFSILKKHKIIH | 321 | Q03936 | |
| LKKKRSLLNSHILHL | 1461 | Q8IZQ1 | |
| TLHDKHREVRLKCVK | 351 | Q9UJ98 | |
| LKKKGKEIFHRLHLS | 201 | P0CI26 | |
| KAFHAIILLEKHLRE | 816 | Q96K83 | |
| RIKKTLTKHLVIHSD | 706 | Q5SVQ8 | |
| ATKLRRHLKSHLEDK | 591 | Q9H9D4 | |
| SRLAKVVKTLKEIHL | 121 | Q15833 | |
| KLLRHLKQKDRLLHK | 181 | Q9Y2I9 | |
| LLKKHKRLEGELVAH | 1751 | P02549 | |
| TRSIVKILHDHKILI | 3211 | Q86WI1 | |
| HLDFHVKDLIKKLLV | 266 | P51817 | |
| HICHVARKEEILLIK | 1611 | P27708 | |
| RLDNLKAHLKIHSKE | 501 | O43167 | |
| LLHLREFDKKKLISV | 536 | Q12931 | |
| KESILSLLIKLHHKL | 1086 | Q6ZT12 | |
| RSHEHLIRLLLEKGK | 26 | Q9HD40 | |
| KIDKEIELHRILHHK | 126 | Q9NYY3 | |
| ILDRHLAILSKKHLE | 106 | O14530 | |
| SKDHIALTLKRLQKI | 1161 | Q6ZQQ6 | |
| HLRKELLIAAKHILT | 326 | Q9Y4A5 | |
| LLAHIIAKFAIHKKI | 1886 | Q9Y4A5 | |
| IHKKIVLQVFHSLLK | 1896 | Q9Y4A5 | |
| LKGLKQEHRLLSLHI | 331 | Q9H267 | |
| LFKKKSHLLVHQRIH | 696 | B7Z6K7 | |
| DHLKHLRTLEKTLEK | 516 | Q9C099 | |
| SVRHKLVHLTLKKKS | 1106 | Q13402 | |
| RLKVVHKGRIHKLVI | 476 | Q00872 |